Abstract
A phase IV randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efalizumab in patients with moderate to severe plaque psoriasis involving the scalp
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have